CHIPS+

Optimising the health of young people with HIV in their transition from paediatric to adult care

The aim of the CHIPS+ cohort is to evaluate the longer-term health outcomes of young peopla in adult care who have HIV aquired in adulthood

What is this study about?

Due to improvements in HIV treatment and care, increasing numbers of children with HIV are surviving into adulthood and transitioning from paediatric to adult care. However data collection in CHIPS (the Collaborative HIV Paediatric Study) ceases at time of transfer to adult care, and there is a substantial knowledge gap about long term health outcomes of this group in the UK and Ireland, and worldwide; with CHIPS+ we aim to bridge this gap.

Type of study

Meta-analyses

Contact details

mrcctu.chipsplus@ucl.ac.uk

Who is funding the study?

  • PENTA Foundation
  • NHS England

When is it taking place?

July 2017 to December 2020

Where is it taking place?

NHS clinics across the UK and Ireland

Who is included?

Patients aged ≥15 years who received paediatric HIV care in the UK or Ireland.

Smarter Studies. Global Impact. Better Health.

The MRC Clinical Trials Unit (MRC CTU) at UCL is at the forefront of resolving internationally important questions in infectious diseases and cancer, and delivering swifter and more effective translation of scientific research into patient benefits.